This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 May 20;28(15):2641-7.

doi: 10.1200/JCO.2009.26.3343. Epub 2010 Apr 20.

Randomized phase II trials: inevitable or inadvisable?

Hui K Gan¹, Axel Grothey, Gregory R Pond, Malcolm J Moore, Lillian L Siu, Daniel Sargent

Affiliations

PMID: 20406933
DOI: 10.1200/JCO.2009.26.3343

Randomized phase II trials: inevitable or inadvisable?

Hui K Gan et al. J Clin Oncol. 2010.

. 2010 May 20;28(15):2641-7.

doi: 10.1200/JCO.2009.26.3343. Epub 2010 Apr 20.

Authors

Hui K Gan¹, Axel Grothey, Gregory R Pond, Malcolm J Moore, Lillian L Siu, Daniel Sargent

Affiliation

¹ Princess Margaret Hospital, Toronto, ON, Canada.

PMID: 20406933
DOI: 10.1200/JCO.2009.26.3343

No abstract available

PubMed Disclaimer

Comment in

Randomized phase II trials: misleading and unreliable.
Stewart DJ. Stewart DJ. J Clin Oncol. 2010 Nov 1;28(31):e649-50; author reply e651-3. doi: 10.1200/JCO.2010.31.3254. Epub 2010 Sep 20. J Clin Oncol. 2010. PMID: 20855829 No abstract available.

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.